Abstract
A 59-year-old female complaining of breast tumor with suppurative discharge was diagnosed as having advanced breast cancer (T4cN3M1-StIV), with giant liver metastasis. Seven courses of combined chemoendocrine therapy (CTF + MPA) were used. Following the chemoendocrine therapy, primary tumor, lung, pleural, supraclavicular and parasternal metastasis disappeared, and the liver metastasis was obviously diminished. These effects continued for 1 year 7 months. Although CTF + MPA chemoendocrine therapy is widely used with advanced or recurrent breast cancer, a clearly effective case has almost never been reported. The reason for the remarkable effect in this case was the consistent immunity to breast cancer.
Publication types
-
Case Reports
-
English Abstract
MeSH terms
-
Antineoplastic Agents, Hormonal / administration & dosage*
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Bone Neoplasms / secondary
-
Breast Neoplasms / drug therapy*
-
Breast Neoplasms / pathology
-
Carcinoma, Ductal, Breast / drug therapy*
-
Carcinoma, Ductal, Breast / secondary
-
Cyclophosphamide / administration & dosage
-
Doxorubicin / administration & dosage
-
Doxorubicin / analogs & derivatives
-
Drug Administration Schedule
-
Female
-
Fluorouracil / administration & dosage
-
Humans
-
Liver Neoplasms / secondary
-
Lung Neoplasms / secondary
-
Lymphatic Metastasis
-
Medroxyprogesterone Acetate / administration & dosage*
-
Middle Aged
Substances
-
Antineoplastic Agents, Hormonal
-
Doxorubicin
-
Cyclophosphamide
-
Medroxyprogesterone Acetate
-
pirarubicin
-
Fluorouracil